Close

More on NVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+6.4% Growth)
- Ratings (3.3 Score)
- Holders
- Event Driven Deals

Upcoming Events

- Earnings (7/18/23)
- M&A (3/31/20 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Novartis (NY:NVS)
Delayed: 98.63 -1.03 (1.03%)
Prev. Close $99.66  
Open$99.93 
52 Wk High$89.15 
52 Wk Low$69.84 
Day High$100.00 
Day Low$98.30 
P/E N/A  
EPS$0.00 
Volume1,315,681 

Friends, Peers and Foes (?): NOVN:SW, NOVN, FRC, COIN, PINS (more...)

Jun 6, 2023 05:04 AM UBS Reiterates Neutral Rating on Novartis (NOVN:SW) (NVS)
Jun 6, 2023 04:23 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF110 at Deutsche Bank
Jun 5, 2023 03:15 AM Morgan Stanley Reiterates Underweight Rating on Novartis (NOVN:SW) (NVS)
Jun 2, 2023 08:06 AM Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Jun 2, 2023 08:01 AM Novartis's (NVS) Kisqali Cut Risk Of Tumors Returning By 25%
May 31, 2023 04:01 PM Form SD NOVARTIS AG
May 24, 2023 11:38 AM Novartis (NVS) option IV near low end of range
May 18, 2023 05:39 AM Novartis (NOVN:SW) (NVS) PT Raised to CHF99 at UBS
May 17, 2023 01:59 PM Sandoz Canada improves patients’ access to treatment with the launch of three new generics
May 15, 2023 05:05 PM Form 20-F/A NOVARTIS AG For: Dec 31
View All Articles

Entities mentioned with NVS

View All Entities